Examining the effects of Brexit on a Worthing pharmaceutical firm

Home › Examining the effects of Brexit on a Worthing pharmaceutical firm

Once the UK leaves the EU, new drugs will have to be tested here and in Europe.

22.11	Formulating Biphasic and Triphasic Products
22.11	Gatwick terminal evacuated due to security risk
22.11	68% of US households have a smart TV, 46% have a streaming media player
22.11	Reliance and Disney complete India JV transaction
22.11	HbbTV Association appoints Service List Registry
22.11	ocilion brings Prime Video and YouTube to its IPTV platform
22.11	WISI's Inca IP Video Platform supports A3SA-protected content
22.11	Bitmovin launches AI-powered contextual advertising
Consumer Goods and Services »

je.st